tiprankstipranks
Trending News
More News >
Goodbody Health (GDBYF)
OTHER OTC:GDBYF
US Market

Goodbody Health (GDBYF) Ratios

Compare
45 Followers

Goodbody Health Ratios

GDBYF's free cash flow for Q3 2022 was C$0.45. For the 2022 fiscal year, GDBYF's free cash flow was decreased by C$ and operating cash flow was C$-0.52. See a summary of the company’s cash flow.
Ratios
TTM
Dec 21Dec 20Dec 19Dec 18
Liquidity Ratios
Current Ratio
2.03 2.00 4.50--
Quick Ratio
1.87 1.74 4.16--
Cash Ratio
1.69 1.30 3.32--
Solvency Ratio
-0.34 -2.18 -3.37--
Operating Cash Flow Ratio
0.52 -1.63 -4.36--
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00--
Net Current Asset Value
C$ 3.52MC$ 963.33KC$ 1.65M--
Leverage Ratios
Debt-to-Assets Ratio
0.03 0.06 0.14--
Debt-to-Equity Ratio
0.05 0.08 0.18--
Debt-to-Capital Ratio
0.05 0.07 0.15--
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00--
Financial Leverage Ratio
1.53 1.31 1.30--
Debt Service Coverage Ratio
0.00 -147.72 0.00--
Interest Coverage Ratio
0.00 -165.28 0.00--
Debt to Market Cap
0.00 0.00 0.00--
Interest Debt Per Share
<0.01 0.03 0.08--
Net Debt to EBITDA
417.21 0.33 0.42--
Profitability Margins
Gross Profit Margin
52.36%56.35%52.03%--
EBIT Margin
-6.20%-230.23%-245.12%--
EBITDA Margin
-0.08%-206.59%-227.21%--
Operating Profit Margin
-6.20%-223.96%-229.03%--
Pretax Profit Margin
-13.17%-240.04%-261.99%--
Net Profit Margin
-13.57%-233.61%-261.99%--
Continuous Operations Profit Margin
-13.57%-233.58%-261.99%--
Net Income Per EBT
102.98%97.32%100.00%--
EBT Per EBIT
212.58%107.18%114.39%--
Return on Assets (ROA)
-21.34%-56.75%-83.43%--
Return on Equity (ROE)
-34.66%-74.13%-108.48%--
Return on Capital Employed (ROCE)
-14.57%-66.00%-84.01%--
Return on Invested Capital (ROIC)
-14.70%-62.67%-85.50%--
Return on Tangible Assets
-22.60%-69.23%-95.42%--
Earnings Yield
-877043.08%-4087.62%-1935.06%--
Efficiency Ratios
Receivables Turnover
40.38 11.19 4.98--
Payables Turnover
0.00 0.00 0.00--
Inventory Turnover
13.80 2.30 3.35--
Fixed Asset Turnover
5.79 0.52 1.19--
Asset Turnover
1.57 0.24 0.32--
Working Capital Turnover Ratio
6.62 1.12 1.35--
Cash Conversion Cycle
35.48 191.25 182.42--
Days of Sales Outstanding
9.04 32.61 73.36--
Days of Inventory Outstanding
26.44 158.64 109.06--
Days of Payables Outstanding
0.00 0.00 0.00--
Operating Cycle
35.48 191.25 182.42--
Cash Flow Ratios
Operating Cash Flow Per Share
0.05 -0.14 -0.33--
Free Cash Flow Per Share
0.05 -0.16 -0.39--
CapEx Per Share
<0.01 0.02 0.07--
Free Cash Flow to Operating Cash Flow
0.86 1.10 1.20--
Dividend Paid and CapEx Coverage Ratio
7.32 -9.55 -4.97--
Capital Expenditure Coverage Ratio
7.32 -9.55 -4.97--
Operating Cash Flow Coverage Ratio
5.51 -4.70 -4.21--
Operating Cash Flow to Sales Ratio
0.11 -1.18 -1.80--
Free Cash Flow Yield
575876.28%-2275.98%-1599.11%--
Valuation Ratios
Price-to-Earnings (P/E) Ratio
>-0.01 -0.02 -0.05--
Price-to-Sales (P/S) Ratio
<0.01 0.06 0.14--
Price-to-Book (P/B) Ratio
<0.01 0.02 0.06--
Price-to-Free Cash Flow (P/FCF) Ratio
<0.01 -0.04 -0.06--
Price-to-Operating Cash Flow Ratio
<0.01 -0.05 -0.08--
Price-to-Earnings Growth (PEG) Ratio
>-0.01 <0.01 >-0.01--
Price-to-Fair Value
<0.01 0.02 0.06--
Enterprise Value Multiple
417.19 0.31 0.36--
Enterprise Value
-5.73M -1.26M -1.18M--
EV to EBITDA
417.19 0.31 0.36--
EV to Sales
-0.34 -0.63 -0.81--
EV to Free Cash Flow
-3.58 0.49 0.37--
EV to Operating Cash Flow
-3.09 0.54 0.45--
Tangible Book Value Per Share
0.19 0.30 0.37--
Shareholders’ Equity Per Share
0.20 0.39 0.44--
Tax and Other Ratios
Effective Tax Rate
-0.03 0.03 -0.06--
Revenue Per Share
0.49 0.12 0.18--
Net Income Per Share
-0.07 -0.29 -0.48--
Tax Burden
1.03 0.97 1.00--
Interest Burden
2.13 1.04 1.07--
Research & Development to Revenue
0.00 0.00 0.00--
SG&A to Revenue
0.25 2.38 2.44--
Stock-Based Compensation to Revenue
0.02 0.55 0.50--
Income Quality
-0.83 0.49 0.69--
Currency in CAD